Biopharma 4.0: How Ireland and India can shape the next era of smart manufacturing
The global biopharma sector is entering a moment where the old rules of competitiveness are being rewritten. For decades, market…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Guest Blogs
CDSCO proposes to ban “Same Brand, Different Drug” practice
Regulator introduces “One Brand – One Formulation” policy to improve patient safety and reduce medication errors
In a landmark…
What India and Africa can teach each other on animal health – A rare IMEA-wide view on disease…
Animal health has become one of the defining priorities for agriculture across India, the Middle East and Africa (IMEA).…
The GLP-1 effect: How weight-loss drugs could reshape India’s FMCG playbook
Everyone is talking about GLP-1 as the next big healthcare disruptor. That is only half the story. If a drug can make people feel…
The shift to intelligence driven pharma
Pharmaceutical companies are experiencing a substantial transformation compared to how they operated in prior decades. Previously,…
Accessibility through agility: Building manufacturing and access systems that deliver affordable…
Across the pharmaceutical industry, one thing is clear: being efficient doesn't make medicines affordable on its own.…
AI-driven QbD: Advancing predictive, data-driven pharma formulation development using artificial…
Introduction: Moving beyond conventional QbD
Quality by Design (QbD) has become a cornerstone of pharmaceutical development by…
Lessons from the Delhi–Agra–Puducherry counterfeit medicine investigation
Introduction
India is often described as the “pharmacy of the world.” Yet, the growing menace of counterfeit and substandard…
From packaging to patient outcomes: Why India’s latest DPCO amendment signals a new direction for…
The pharmaceutical industry has traditionally regarded packaging as the final stage of manufacturing—a necessary component that…
What stays on the top of pharma shelf—ease of doing business or patient safety?
Three individuals allegedly bought expired medicines at scrap prices, relabelled them with professionally printed stickers,…
Beyond the batch: How digital twins are rewriting the rules of medicine
Amit Malviya, VP – QA, Zest Pharma, highlights how digital twins, AI and real-time release testing are reshaping pharmaceutical…
Six business lessons from Cipla’s nine-decade journey
Author Vijay Martis explains how Cipla's business model, strategy and purpose shaped its growth over nine decades
USFDA and EUDRA dashboards offer lessons for strengthening India’s regulatory transparency
Milind Sathe analyses how public regulatory dashboards can support pharmaceutical innovation, compliance and patient safety in…
From fintech to aesthetic injectables: Lessons in navigating regulatory formalisation
Rishi Agrawal, CEO, TeamLease RegTech cautions that the recent CDSCO clarification on injectable cosmetic products signals a…
Why ingredient transparency matters more than ever in cosmeceuticals
Dr Aisshwarya Panddit highlights why ingredient transparency has become essential in modern cosmeceuticals amid rising consumer…
Beyond ozempic: GLP-1s and the next wave of anti-obesity drugs
Saloni Paliwal, Co-founder, Voy India highlights the evolution of GLP-1 therapies beyond Ozempic, examining the science, market…
India patent office can bridge the gap with global patent search platforms
The author highlights how India’s patent search ecosystem compares with WIPO, USPTO and Espacenet, and outlines the features…
How India reimagined healthcare in 12 years—and what comes next
Anil Matai, Director General, OPPI reflects on more than a decade of sweeping transformation under the leadership of Hon. Prime…
Pharmacy beyond pills: Why India needs better drug awareness and pharmacy practice
Dr Ashok Omray examines India’s growing culture of self-medication and highlights the urgent need for stronger pharmacy awareness…
An emerging disruption in drug traceability for India and beyond
Over the past two decades, I have worked closely on serialisation and traceability deployments in multiple markets, transitioning…